Evidence map›Paper›PMID 40333326›Full record

ArticleVaccines2025

Destabilising Effect of Class B CpG Adjuvants on Different Proteins and Vaccine Candidates.

Kawkab Kanjo, Rakesh Lothe, Gaurav Nagar, Meghraj Rajurkar, Harish Rao, Saurabh Batwal, Umesh Shaligram, Raghavan Varadarajan

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kawkab KanjoMolecular Biophysics Unit, Indian Institute of Science, Bangalore 560012, India.ORCID 0000-0002-3214-4848
Rakesh LotheSerum Institute of India Pvt. Ltd., Pune 411028, India.
Gaurav NagarSerum Institute of India Pvt. Ltd., Pune 411028, India.
Meghraj RajurkarSerum Institute of India Pvt. Ltd., Pune 411028, India.
Harish RaoSerum Institute of India Pvt. Ltd., Pune 411028, India.
Saurabh BatwalSerum Institute of India Pvt. Ltd., Pune 411028, India.
Umesh ShaligramSerum Institute of India Pvt. Ltd., Pune 411028, India.
Raghavan VaradarajanMolecular Biophysics Unit, Indian Institute of Science, Bangalore 560012, India.ORCID 0000-0002-0823-7577

Funding

Bill & Melinda Gates Foundation INV-042471Biotechnology Industry Research Assistance Council BT/COVID0093/01/20
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvantCpGproteolytic sensitivitySARS-CoV-2 RBDstabilitythermal stabilityvaccine

Identifiers

PMID40333326
PMCPMC12031019

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.